Unveiling the Veil of Deception: Lifecore Biomedical, Inc. Faces Securities Fraud Allegations
Investors Alerted to Misleading Financial Statements A recent lawsuit against Lifecore Biomedical, Inc. (“Lifecore”), symbolized as LFCR on the NASDAQ, beckons investors who sustained substantial losses between October 7, 2020, and March 19, 2024, to partake in a securities fraud class action. The Law Offices …